You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

Claims for Patent: 6,319,192

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,319,192

Title:	Method for the treatment of fertility disorders
Abstract:	An improvement to the method of intrauterine insemination by the administration of luteinizing hormone-releasing hormone antagonists (LHRH antagonists).
Inventor(s):	Engel; Jurgen (Alzenau, DE), Riethmuller-Winzen; Hilde (Frankfurt, DE), Reissmann; Thomas (Frankfurt, DE)
Assignee:	Zentaris AG (Frankfurt am Main, DE)
Application Number:	09/296,610
Patent Claims:	1. In the method of therapeutic management of infertility by intrauterine insemination, the improvement consisting of a) the dose-dependent suppression of endogenous gonadotropins, especially LH, with an LH-RH antagonist allowing the maintenance of physiological oestrogen levels b) exogenous stimulation of the ovarian follicle growth c) ovulation induction with HCG, native LHRH, LHRH agonists or recombinant LH d) intrauterine insemination by sperm injection. 2. The method of therapeutic management of infertility by intrauterine insemination according to claim 1 in which the LHRH antagonist is cetrorelix. 3. The method of therapeutic management of infertility by intrauterine insemination according to claim 1 in which he LHRH antagonist is antarelix. 4. The method of therapeutic management of infertility by intrauterine insemination according to claim 1 in which ovarian follicle stimulation is performed by administration of urinary or recombinant FSH or HMG, with or without recombinant LH. 5. The method of therapeutic management of infertility by intrauterine insemination according to claim 1 in which ovarian follicle stimulation is achieved with antioestrogens. 6. The method of therapeutic management of infertility by intrauterine insemination according to claim 1 in which ovarian follicle stimulation is achieved with the combination of antioestrogens with gonadotropins.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.